Sanatio Pharmaceuticals Private Limited, a active private limited company, was established on 04 January 2016 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74120MH2016PTC271652. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Pramod Santbux Singh (Director), Birendrakumar Ramavadh Yadav (Director). Past directors included Meena Birendra Yadav, Akbar Ali Ameer Mohideen Shaikh, Jitendra Ramawadh Yadav. It holds ₹5.00 M open charges and ₹5.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No-1, Snehlata Sadani Chimat Pada, Marol Naka, Andheri (East), Mumbai, Maharashtra, 400059.
U74120MH2016PTC271652
271652
04 January 2016
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sanatio Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramod Santbux Singh | Director | 24 Apr 2023 | Current |
| Birendrakumar Ramavadh Yadav | Director | 04 Jan 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Director | 28 Jun 2023 | Past |
| Pramod Abcsdd | Director | 27 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanatio Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 45.36% increase. The company also saw a slight improvement in profitability, with a 2.61% increase in profit. The company's net worth Soared by an impressive increase of 41.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sanatio Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹5,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Apr 2021 | Others | ₹5.00 M | Open |
| 22 Feb 2019 | Others | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sanatio Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sanatio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanatio Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sanatio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Sanatio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Pramod Santbux Singh was appointed as a Director was appointed as a Director on 24 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Progress on A charge registered on 22 Feb 2019 via Charge ID 100246113 with Others was fully satisfied on 17 May 2021. was documented.
Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100442275 was registered on 22 Apr 2021. was documented.
The activity A charge with Others amounted to Rs. 5.50 M with Charge ID 100246113 was registered on 22 Feb 2019. was completed.
The CIN of Sanatio Pharmaceuticals Private Limited is U74120MH2016PTC271652.
Sanatio Pharmaceuticals Private Limited is headquartered at Shop No-1, Snehlata Sadani Chimat Pada, Marol Naka, Andheri (East), Mumbai, Maharashtra, 400059.
Sanatio Pharmaceuticals Private Limited was incorporated on 04 January 2016.
The current directors of Sanatio Pharmaceuticals Private Limited are
The primary industry of Sanatio Pharmaceuticals Private Limited is Trade.
Sanatio Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sanatio Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sanatio Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX